Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -69,417 | -57,858 | -49,553 | -19,995 | -10,528 |
| Depreciation Amortization | 1,633 | 1,928 | 1,469 | 1,515 | 1,790 |
| Accounts receivable | -60,738 | -422 | 681 | -913 | 1,102 |
| Other Working Capital | 63,293 | 416 | -218 | 254 | -4,140 |
| Other Operating Activity | 75,451 | 9,418 | 12,311 | 4,519 | -356 |
| Operating Cash Flow | $10,222 | $-46,518 | $-35,310 | $-14,620 | $-12,132 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -43,805 | 21,007 | 4,307 | -42,774 | N/A |
| PPE Investments | -2,870 | -4,702 | -1,696 | -338 | -50 |
| Net Acquisitions | 33,607 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-13,068 | $16,305 | $2,611 | $-43,112 | $-50 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 17,000 | N/A | 20,000 | 39,957 | 9,690 |
| Debt Repayment | -14,357 | -1,115 | -21,692 | -1,000 | -845 |
| Common Stock Issued | N/A | 31,701 | 34,824 | 21,360 | 2,464 |
| Other Financing Activity | 439 | -383 | -316 | -2,476 | 22 |
| Financing Cash Flow | $3,082 | $30,203 | $32,816 | $57,841 | $11,331 |
| Beginning Cash Position | 704 | 714 | 597 | 488 | 1,339 |
| End Cash Position | 940 | 704 | 714 | 597 | 488 |
| Net Cash Flow | $236 | $-10 | $117 | $109 | $-851 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,222 | -46,518 | -35,310 | -14,620 | -12,132 |
| Capital Expenditure | -2,974 | -4,702 | -1,696 | -338 | -50 |
| Free Cash Flow | 7,248 | -51,220 | -37,006 | -14,958 | -12,182 |